Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Smith Hunter C
Chief Financial Officer at RHYTHM PHARMACEUTICALS. Filing since 15 Feb 2022.
CIK 0001636385
Company
Date
Role
Action
Shares
Amount
Of holding
RYTM
RHYTHM PHARMACEUTICALS, INC.
31 Aug 2026
Chief Financial Officer
Sold on a plan
62,774
$6.62M
35.5%
RYTM
RHYTHM PHARMACEUTICALS, INC.
19 Feb 2026
Chief Financial Officer
Sold on a plan
4,385
$444.00K
3.8%
RYTM
RHYTHM PHARMACEUTICALS, INC.
17 Feb 2026
Chief Financial Officer
Sold on a plan
3,569
$361.81K
3.0%
RYTM
RHYTHM PHARMACEUTICALS, INC.
12 Feb 2026
Chief Financial Officer
Sold on a plan
1,592
$156.38K
1.3%
RYTM
RHYTHM PHARMACEUTICALS, INC.
11 Feb 2026
Chief Financial Officer
Sold on a plan
2,766
$272.77K
2.3%
RYTM
RHYTHM PHARMACEUTICALS, INC.
10 Feb 2026
Chief Financial Officer
Sold on a plan
2,713
$279.43K
2.2%
RYTM
RHYTHM PHARMACEUTICALS, INC.
5 Feb 2026
Chief Financial Officer
Sold on a plan
3,381
$358.60K
2.6%
RYTM
RHYTHM PHARMACEUTICALS, INC.
4 Feb 2026
Chief Financial Officer
Sold on a plan
3,247
$344.15K
2.5%
RYTM
RHYTHM PHARMACEUTICALS, INC.
13 Aug 2025
Chief Financial Officer
Sold on a plan
3,477
$333.79K
2.9%
RYTM
RHYTHM PHARMACEUTICALS, INC.
12 Aug 2025
Chief Financial Officer
Sold on a plan
24,611
$2.37M
17.4%
RYTM
RHYTHM PHARMACEUTICALS, INC.
9 Jul 2025
Chief Financial Officer
Sold on a plan
42,120
$3.39M
26.5%
RYTM
RHYTHM PHARMACEUTICALS, INC.
30 May 2025
Chief Financial Officer
Sold on a plan
23,400
$1.44M
17.6%
RYTM
RHYTHM PHARMACEUTICALS, INC.
19 Feb 2025
Chief Financial Officer
Sold on a plan
2,215
$126.74K
2.0%
RYTM
RHYTHM PHARMACEUTICALS, INC.
12 Feb 2025
Chief Financial Officer
Sold on a plan
751
$42.35K
0.7%
RYTM
RHYTHM PHARMACEUTICALS, INC.
11 Feb 2025
Chief Financial Officer
Sold on a plan
1,296
$74.53K
1.2%
RYTM
RHYTHM PHARMACEUTICALS, INC.
4 Feb 2025
Chief Financial Officer
Sold at will
1,678
$99.72K
1.6%
RYTM
RHYTHM PHARMACEUTICALS, INC.
19 Mar 2024
Chief Financial Officer
Sold at will
15,515
$608.50K
13.7%
RYTM
RHYTHM PHARMACEUTICALS, INC.
13 Feb 2024
Chief Financial Officer
Sold at will
709
$35.32K
0.9%
RYTM
RHYTHM PHARMACEUTICALS, INC.
12 Feb 2024
Chief Financial Officer
Sold at will
1,209
$62.12K
1.5%
RYTM
RHYTHM PHARMACEUTICALS, INC.
1 Feb 2024
Chief Financial Officer
Sold at will
1,616
$72.82K
2.1%
RYTM
RHYTHM PHARMACEUTICALS, INC.
6 Dec 2023
Chief Financial Officer
Sold at will
20,000
$800.00K
24.6%
RYTM
RHYTHM PHARMACEUTICALS, INC.
5 Dec 2023
Chief Financial Officer
Sold at will
7,026
$246.36K
10.3%
RYTM
RHYTHM PHARMACEUTICALS, INC.
24 Nov 2023
Chief Financial Officer
Sold at will
10,974
$384.34K
15.2%
RYTM
RHYTHM PHARMACEUTICALS, INC.
14 Nov 2023
Chief Financial Officer
Sold at will
12,000
$364.57K
16.3%
RYTM
RHYTHM PHARMACEUTICALS, INC.
14 Feb 2023
Chief Financial Officer
Sold, plan not stated
702
$18.86K
1.2%
RYTM
RHYTHM PHARMACEUTICALS, INC.
9 Feb 2023
Chief Financial Officer
Sold, plan not stated
1,398
$38.67K
2.4%
RYTM
RHYTHM PHARMACEUTICALS, INC.
1 Jul 2022
Chief Financial Officer
Sold, plan not stated
7,547
$30.79K
11.6%
RYTM
RHYTHM PHARMACEUTICALS, INC.
15 Feb 2022
Chief Financial Officer
Sold, plan not stated
833
$5.08K
2.0%
28 decisions on file.
